PL2054028T3 - Podskórne implanty uwalniające aktywny składnik przez przedłużony okres czasu - Google Patents
Podskórne implanty uwalniające aktywny składnik przez przedłużony okres czasuInfo
- Publication number
- PL2054028T3 PL2054028T3 PL07788130T PL07788130T PL2054028T3 PL 2054028 T3 PL2054028 T3 PL 2054028T3 PL 07788130 T PL07788130 T PL 07788130T PL 07788130 T PL07788130 T PL 07788130T PL 2054028 T3 PL2054028 T3 PL 2054028T3
- Authority
- PL
- Poland
- Prior art keywords
- time
- extended period
- active principle
- subcutaneous implants
- principle over
- Prior art date
Links
- 239000007943 implant Substances 0.000 title 1
- 238000007920 subcutaneous administration Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT001539A ITMI20061539A1 (it) | 2006-08-02 | 2006-08-02 | Impianti sottocutanei in grado di rilasciare il principio attivo per un periodo prolungato di tempo |
| EP07788130A EP2054028B9 (en) | 2006-08-02 | 2007-08-01 | Subcutaneous implants releasing an active principle over an extended period of time |
| PCT/EP2007/057961 WO2008015232A1 (en) | 2006-08-02 | 2007-08-01 | Subcutaneous implants releasing an active principle over an extended period of time |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2054028T3 true PL2054028T3 (pl) | 2013-02-28 |
Family
ID=37765841
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL07788130T PL2054028T3 (pl) | 2006-08-02 | 2007-08-01 | Podskórne implanty uwalniające aktywny składnik przez przedłużony okres czasu |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20090246245A1 (pl) |
| EP (1) | EP2054028B9 (pl) |
| JP (1) | JP2009545351A (pl) |
| KR (1) | KR20090046837A (pl) |
| CN (1) | CN101522169B (pl) |
| AU (1) | AU2007280391A1 (pl) |
| BR (1) | BRPI0714818A2 (pl) |
| CA (1) | CA2658592A1 (pl) |
| EA (1) | EA017473B1 (pl) |
| ES (1) | ES2389981T3 (pl) |
| IT (1) | ITMI20061539A1 (pl) |
| MX (1) | MX2009001231A (pl) |
| PL (1) | PL2054028T3 (pl) |
| PT (1) | PT2054028E (pl) |
| WO (1) | WO2008015232A1 (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10753023B2 (en) | 2010-08-13 | 2020-08-25 | Kimberly-Clark Worldwide, Inc. | Toughened polylactic acid fibers |
| US8936740B2 (en) | 2010-08-13 | 2015-01-20 | Kimberly-Clark Worldwide, Inc. | Modified polylactic acid fibers |
| WO2012088304A2 (en) * | 2010-12-22 | 2012-06-28 | Psivida Us, Inc. | Two-piece injectable drug delivery device with heat-cured seal |
| WO2014076703A1 (en) * | 2012-11-14 | 2014-05-22 | Silenseed Ltd. | Methods and compositions for treating cancer |
| CA2989171A1 (en) * | 2015-06-18 | 2016-12-22 | Acuitybio Corporation | Implantable drug delivery compositions and methods of use thereof |
| JP2021529747A (ja) * | 2018-06-25 | 2021-11-04 | タイタン ファーマシューティカルズ インコーポレイテッド | 親油性又は両親媒性医薬物質の放出のためのインプラント |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1304152B1 (it) * | 1998-12-10 | 2001-03-08 | Mediolanum Farmaceutici Srl | Composizioni comprendenti un peptide ed acido polilattico-glicolicoatte alla preparazione di impianti sottocutanei aventi un prolungato |
| WO2003000237A2 (en) * | 2001-06-22 | 2003-01-03 | Johns Hopkins University School Of Medicine | Biodegradable polymer coompositions |
| DE602004007802T2 (de) * | 2003-06-26 | 2008-04-17 | Mediolanum Pharmaceuticals Ltd. | Subcutane implantate mit begrenzter initialer wirkstoff-freisetzung und deren anschliessende lineare veränderliche verlängerte freisetzung |
| ITMI20031302A1 (it) * | 2003-06-26 | 2004-12-27 | Mediolanum Pharmaceuticals Ltd | Uso di etanolo come plasticizzante per preparare impianti sottocutanei contenenti principi attivi termolabili dispersi in una matrice di plga. |
| WO2005110374A1 (en) * | 2004-04-30 | 2005-11-24 | Allergan, Inc. | Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component |
-
2006
- 2006-08-02 IT IT001539A patent/ITMI20061539A1/it unknown
-
2007
- 2007-08-01 EA EA200901148A patent/EA017473B1/ru not_active IP Right Cessation
- 2007-08-01 JP JP2009522272A patent/JP2009545351A/ja active Pending
- 2007-08-01 BR BRPI0714818-6A patent/BRPI0714818A2/pt not_active IP Right Cessation
- 2007-08-01 CN CN2007800364294A patent/CN101522169B/zh not_active Expired - Fee Related
- 2007-08-01 WO PCT/EP2007/057961 patent/WO2008015232A1/en not_active Ceased
- 2007-08-01 US US12/309,790 patent/US20090246245A1/en not_active Abandoned
- 2007-08-01 AU AU2007280391A patent/AU2007280391A1/en not_active Abandoned
- 2007-08-01 MX MX2009001231A patent/MX2009001231A/es active IP Right Grant
- 2007-08-01 PL PL07788130T patent/PL2054028T3/pl unknown
- 2007-08-01 KR KR1020097003184A patent/KR20090046837A/ko not_active Withdrawn
- 2007-08-01 PT PT07788130T patent/PT2054028E/pt unknown
- 2007-08-01 EP EP07788130A patent/EP2054028B9/en not_active Not-in-force
- 2007-08-01 ES ES07788130T patent/ES2389981T3/es active Active
- 2007-08-01 CA CA002658592A patent/CA2658592A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN101522169B (zh) | 2013-02-20 |
| ES2389981T3 (es) | 2012-11-05 |
| KR20090046837A (ko) | 2009-05-11 |
| MX2009001231A (es) | 2009-04-28 |
| EP2054028B1 (en) | 2012-06-27 |
| JP2009545351A (ja) | 2009-12-24 |
| CA2658592A1 (en) | 2008-02-07 |
| ITMI20061539A1 (it) | 2008-02-03 |
| PT2054028E (pt) | 2012-10-10 |
| US20090246245A1 (en) | 2009-10-01 |
| AU2007280391A1 (en) | 2008-02-07 |
| WO2008015232A8 (en) | 2008-05-22 |
| EP2054028B9 (en) | 2012-09-26 |
| HK1131546A1 (en) | 2010-01-29 |
| WO2008015232A1 (en) | 2008-02-07 |
| EA017473B1 (ru) | 2012-12-28 |
| EA200901148A1 (ru) | 2010-02-26 |
| EP2054028A1 (en) | 2009-05-06 |
| CN101522169A (zh) | 2009-09-02 |
| BRPI0714818A2 (pt) | 2013-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2151213A4 (en) | BIONIC DENTAL IMPLANT | |
| EP2262450A4 (en) | IMPLANTS AND METHODS OF USE | |
| GB2459634B (en) | Activation of surgical implants | |
| EP2081520A4 (en) | MEDICAL IMPLANTS | |
| ZA201000013B (en) | Medical implant | |
| IL198765A0 (en) | Supraosseous dental implant | |
| PL3505139T3 (pl) | Wszczepialne urządzenia medyczne zawierające stopy biodegradowalne | |
| GB0610867D0 (en) | Treatment of pain | |
| PL2344063T3 (pl) | Implant stomatologiczny | |
| ZA201001417B (en) | Medical implant | |
| EP2001427A4 (en) | INTRAOCULAR IMPLANT | |
| EP2378983A4 (en) | IMPLANTABLE PROSTHESIS | |
| IL193748A0 (en) | Treatment of pain | |
| IL194506A0 (en) | Implants for the treatment of dopamine associated states | |
| ZA201107583B (en) | Dental implant assembly and component | |
| EP2051651A4 (en) | LASER TREATMENT OF TISSUE | |
| ZA201007436B (en) | Encapsulation of biologically active agents | |
| EP2097042A4 (en) | IMPLANTABLE INTRAVASCULAR DEVICE HAVING A SUPERIOR ANCHORING ARRANGEMENT | |
| PL2328507T3 (pl) | Wszczep stomatologiczny | |
| GB0618930D0 (en) | Medical implant | |
| PL2054028T3 (pl) | Podskórne implanty uwalniające aktywny składnik przez przedłużony okres czasu | |
| EP2379006A4 (en) | IMPLANTABLE MATERIALS FOR MINIMAL TISSUE FIXATION | |
| EP2008612A4 (en) | IMPROVED DENTAL IMPLANT | |
| ZA201007437B (en) | Encapsulation of biologically active agents | |
| EP2326286A4 (en) | IMPLANTED MEDICAL DEVICE |